211555-08-7 Usage
Uses
Used in Pharmaceutical Research:
Phenol, 3-[(6,7-diMethoxy-4-quinazolinyl)aMino]is used as a research compound for its potential anti-cancer properties. It is being studied for its ability to target and inhibit the growth of cancer cells, making it a candidate for the development of new cancer therapeutics.
Used in Drug Development:
In the field of drug development, Phenol, 3-[(6,7-diMethoxy-4-quinazolinyl)aMino]is utilized as a lead compound for the creation of new pharmaceuticals. Its anti-inflammatory properties are of particular interest, as they may contribute to the treatment of various inflammatory conditions.
Used in Medicinal Chemistry:
Phenol, 3-[(6,7-diMethoxy-4-quinazolinyl)aMino]is employed in medicinal chemistry as a structural template for the design and synthesis of novel bioactive molecules. Its unique structure allows for modifications that can enhance its therapeutic potential and selectivity.
Used in Toxicology Studies:
Due to its potential toxicity, Phenol, 3-[(6,7-diMethoxy-4-quinazolinyl)aMino]is also used in toxicology studies to understand its effects on biological systems and to establish safe handling and usage protocols.
Used in Quality Control and Safety Assessments:
In the pharmaceutical industry, Phenol, 3-[(6,7-diMethoxy-4-quinazolinyl)aMino]is used in quality control processes to ensure the safety and efficacy of drugs that incorporate Phenol, 3-[(6,7-diMethoxy-4-quinazolinyl)aMino]-. It is also utilized in safety assessments to determine the potential health hazards associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 211555-08-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,1,5,5 and 5 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 211555-08:
(8*2)+(7*1)+(6*1)+(5*5)+(4*5)+(3*5)+(2*0)+(1*8)=97
97 % 10 = 7
So 211555-08-7 is a valid CAS Registry Number.
InChI:InChI=1/C16H15N3O3/c1-21-14-7-12-13(8-15(14)22-2)17-9-18-16(12)19-10-4-3-5-11(20)6-10/h3-9,20H,1-2H3,(H,17,18,19)
211555-08-7Relevant academic research and scientific papers
Quinazoline formulations and therapeutic use thereof
-
, (2008/06/13)
Pharmaceutical compositions for parenteral administration of poorly soluble quinazoline compounds in the form of microemulsions or micellar solutions are described. The compositions are useful in treating patients suffering from cancer or having allergic
